Screener
Rigel Pharmaceuticals RIGL Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $78.7M-22.6% | $58.82M+10.3% | $69.8M+21.2% | $69.46M+25.6% | $101.69M+176% | ||
| $8.53M+89.3% | $4.61M+4.5% | $5.96M+2.9% | $4.75M-40.8% | $4.5M+60.5% | ||
| $70.18M-27.8% | $54.21M+10.8% | $63.85M+23.2% | $64.71M+36.9% | $97.18M+186% | ||
| 89.2%-6.4pp | 92.2%+0.4pp | 91.5%+1.5pp | 93.2%+7.7pp | 95.6%+3.2pp | ||
| $13.96M+105% | $11.68M+38.4% | $10.69M+89.7% | $7.35M+18.9% | $6.82M+23.1% | ||
| $32.64M+11.6% | $30.65M+10.6% | $29.99M+1.6% | $28.94M+7.0% | $29.26M+4.3% | ||
| $55.13M+35.8% | $46.93M+15.7% | $46.63M+13.9% | $41.04M-0.5% | $40.58M+11.5% | ||
| $23.58M-61.4% | $11.89M-7.0% | $23.17M+39.1% | $28.42M+102% | $61.1M+13,570% | ||
| 30%-30.1pp | 20.2%-3.7pp | 33.2%+4.3pp | 40.9%+15.5pp | 60.1%+58.9pp | ||
| $779K-58.4% | $1.43M-22.7% | $1.7M-13.1% | $1.89M-8.1% | $1.87M-7.6% | ||
| $23.59M-60.7% | $11.66M+1.3% | $22.71M+49.2% | $27.62M+122% | $59.98M+5,923% | ||
| $6.3M+1,606% | $3M+4,520% | -$245.35M-27,949% | -$280K— | $369K— | ||
| $17.29M-71.0% | $8.65M-24.4% | $268.07M+1,769% | $27.9M+125% | $59.61M+5,888% | ||
| 22%-36.7pp | 14.7%-6.7pp | 384%+359pp | 40.2%+17.7pp | 58.6%+61.4pp | ||
| $0.88-73.2% | $0.44-30.2% | $14.10+1,641% | $1.46+109% | $3.28+5,567% | ||
| $24.42M-60.4% | $12.48M-6.7% | $23.77M+37.7% | $29.02M+97.9% | $61.71M+5,722% | ||
| 31%-29.7pp | 21.2%-3.9pp | 34.1%+4.1pp | 41.8%+15.3pp | 60.7%+57.8pp | ||
| $23.58M-61.4% | $11.89M-7.0% | $23.17M+39.1% | $28.42M+102% | $61.1M+13,570% |
FAQ
- What is Rigel Pharmaceuticals's revenue?
- Rigel Pharmaceuticals (RIGL) generated $276.8M in revenue over the trailing twelve months, up 3.3% year over year.
- Is Rigel Pharmaceuticals profitable?
- Rigel Pharmaceuticals reported $321.9M in net income over the trailing twelve months, a 116.3% net margin.
- What are Rigel Pharmaceuticals's profit margins?
- Gross margin is 91.4% and operating margin is 31.5%, with a 116.3% net margin.
- What is Rigel Pharmaceuticals's earnings per share?
- Rigel Pharmaceuticals's diluted EPS over the trailing twelve months is $16.88.
- Where does Rigel Pharmaceuticals's income statement data come from?
- Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
